Radiopharm Theranostics (RDPTF) Selling, General & Administrative (2023 - 2025)
Powered by 
Analysis
Radiopharm Theranostics (RDPTF) Selling, General & Administrative (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.68 Bn | 197.69 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 180.84 Bn | 177.66 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.50 Bn | 74.50 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 61.49 Bn | 56.31 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 55.01 Bn | 49.87 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.08 Bn | 30.77 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.35 Bn | 30.06 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Radiopharm Theranostics | 23.65 Mn | 23.60 Mn | -92,644.38 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -14.64 Mn |
| Jun 30, 2024 | -13.04 Mn |
| Jun 30, 2023 | -12.23 Mn |